|
WDR7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7679191444131E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.46012149224862E-12 |
| Normal-vs-Stage2 |
4.624900E-04 |
| Normal-vs-Stage3 |
7.95141730236537E-13 |
| Normal-vs-Stage4 |
2.62330046574277E-10 |
| Stage1-vs-Stage2 |
1.314230E-01 |
| Stage1-vs-Stage3 |
1.307410E-01 |
| Stage1-vs-Stage4 |
1.324760E-01 |
| Stage2-vs-Stage3 |
3.580100E-02 |
| Stage2-vs-Stage4 |
2.776000E-02 |
| Stage3-vs-Stage4 |
7.159000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-15 |
| Normal-vs-AfricanAmerican |
1.505750E-02 |
| Normal-vs-Asian |
1.24260002287713E-09 |
| Caucasian-vs-AfricanAmerican |
7.304400E-03 |
| Caucasian-vs-Asian |
7.473800E-01 |
| AfricanAmerican-vs-Asian |
7.757000E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67730274114319E-11 |
| Normal-vs-Female |
3.80429021618056E-12 |
| Male-vs-Female |
2.422200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.34710054012066E-11 |
| Normal-vs-Age(41-60Yrs) |
6.04699623707461E-11 |
| Normal-vs-Age(61-80Yrs) |
1.30940003284508E-09 |
| Normal-vs-Age(81-100Yrs) |
1.238210E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.026200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.630000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.857600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.096400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.630000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.865800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.543600E-03 |
| Classical-VS-Follicular |
1.316750E-01 |
| Classical-VS-Other |
1.471440E-01 |
| Classical-VS-Normal |
3.6143310566672E-12 |
| Tall-VS-Follicular |
1.136970E-03 |
| Tall-VS-Other |
7.073400E-01 |
| Tall-VS-Normal |
2.94380075871459E-11 |
| Follicular-VS-Other |
9.526200E-02 |
| Follicular-VS-Normal |
1.59123999999844E-05 |
| Other-VS-Normal |
2.395400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.76310007996506E-10 |
| Normal-vs-N1 |
2.01869632121543E-11 |
| N0-vs-N1 |
2.182500E-02 |
|
|
